← Human Trials & Peer-Reviewed Studies

[Orexin A as mediator in the gut-brain dialogue].

Plain-language guide to PMID 33319349 (2020): review of Orexin-A.

Key Facts

PMID
33319349
Journal
Revista de neurologia
Year
2020
Study type
Review
Authors
Mediavilla C
DOI
10.33588/rn.7112.2020571

What This Paper Covers, in Plain Language

What It Covers

Researchers studied Orexin-A in this review publication.

The source of OXA and the signal(s) triggering its peripheral release are not fully understood, and it is not known whether it acts on orexigenic receptors in peripheral tissues to meet physiological or pathological demands.

The aim of this review is to address these questions in the light of new data indicating that OXA may have functions in the gut-brain axis that go beyond its participation in energy homeostasis.

Why It Was Studied

The orexinergic system is one of the chemical mediators that modulate the gut-brain axis, given the involvement of hypothalamic orexin A (OXA) in gastrointestinal motility and secretion, and the presence of OXA in enteroendocrine cells of the intestinal mucosa and in primary afferent neurons of the mesenteric plexus, permitting its participation in gut-brain signaling.

OXA in the enteric system protects against systemic and central inflammation, and hypothalamic OXA orchestrates numerous peripheral effects to suppress the systemic inflammatory response.

What Was Measured

The orexinergic system is one of the chemical mediators that modulate the gut-brain axis, given the involvement of hypothalamic orexin A (OXA) in gastrointestinal motility and secretion, and the presence of OXA in enteroendocrine cells of the intestinal mucosa and in primary afferent neurons of the mesenteric plexus, permitting its participation in gut-brain signaling.

Topics PubMed links to this paper include Gastrointestinal Tract, Hypothalamus, Mice, Neuroimmunomodulation, Neurons, Neuropeptides and Neurotransmitter Agents.

What This Means in Plain Language

This is a review of Orexin-A.

Its findings take up roughly 2 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (Revista de neurologia), a journal based in Singapore.

More context: the Orexin-A compound page, all human trials.

Our Notes on the Compound

Orexin-A: A brain neuropeptide that keeps people awake; intranasal orexin-A has been tried in small narcolepsy studies.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.